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A number of important issues surrounding local control of
breast cancer continue to attract debate. In breast conserving
surgery, the balance between excising sufficient tissue to
achieve a satisfactory cosmetic outcome while also achieving
adequate long-term local control remains an issue of
contention. Despite the review by Singletary [1] indicating that
wider excisions are unlikely to reduce local recurrence rates,
there remains considerable conflict among surgeons and
radiation oncologists as to what is the optimum width of clear
margin after breast conserving surgery. There has been
increasing focus on trying to identify those patients who are at
significant risk for local recurrence from radiological, patho-
logical and molecular biology perspectives. The radiological
issues have focused on the role played by magnetic resonance
imaging and its value in identifying mammographically occult
disease. There remain some radiologists who advocate its
widespread use, but evidence of its value is limited [2]. Work
by Tabar and coworkers [3] suggests there is a group of
patients with widespread casting type microcalcification on
mammograms; they consider this to represent neoductgenesis,
and it was a poor prognostic sign in their series. Using all of the
information that we are provided with by radiologists and
incorporating mammographic patterns of cancer into prognosis
remains challenging and is an area of controversy.
As well as margins, the pathologist assesses a variety of
factors that have been shown to influence local recurrence,
including histological grade and the presence of lymphatic
vascular invasion. Even with accurate pathology, however, it
is difficult to identify those who will develop local recurrence
with any precision. For this reason, there has been a move to
investigate molecular markers. Gene array profiles have been
investigated recently but cannot yet accurately identify those
patients at risk for local recurrence.
Therefore, the greatest influence on local recurrence after
breast conserving surgery is currently the surgeon’s ability to
reduce the volume of disease within the breast, to a level that
can be adequately controlled by radiotherapy. Thus, the art of
surgery and the ability of the surgeon to remove diseased
tissue while retaining sufficient breast tissue to produce a
satisfactory outcome is a major reason why such surgery is
best carried out by those with a large volume of clinical
experience.
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